Follicle-stimulating hormone stimulates free radical generation without inducing substantial oxidative stress in human granulosa cells

卵泡刺激素可刺激自由基生成,但不会在人颗粒细胞中诱导明显的氧化应激。

阅读:2
作者:Nuan Lin ,Koen C van Zomeren ,Torsten Plosch ,Naomi Hofsink ,Teelkien van Veen ,Hui Ting Li ,Jiazhe Lin ,Xiaoling Zhou ,Henk Groen ,Uwe J F Tietge ,Astrid Cantineau ,Romana Schirhagl ,Annemieke Hoek
STUDY QUESTION: Does FSH induce free radical generation with substantial oxidative damage in human cumulus granulosa cells (cGCs) and mural granulosa cells (mGCs)? SUMMARY ANSWER: FSH of both physiological and supraphysiological concentrations induced free radical generation on subcellular levels, most notably in the mitochondria, while the elevated free radical load caused neglectable oxidative damage in both cGCs and mGCs. WHAT IS KNOWN ALREADY: FSH is fundamental for regulation of granulosa cell (GC) function and oocyte maturation, during which a physiological level of reactive oxygen species (ROS) is essential, while excessive amounts lead to oxidative damage. Potential adverse effects of high FSH doses on GCs may be mediated by ROS. STUDY DESIGN SIZE DURATION: This prospective experimental study included patients who attended a reproductive medicine center in 2023. cGC and mGC were separately isolated and brought into culture on the day of oocyte retrieval, 36 h after ovulation induction with recombinant hCG (250 mg). Recombinant FSH, at different concentrations, mimicking physiological (6 mIU/ml) and supraphysiological (60 and 600 mIU/ml) conditions, was applied (n = 4 in each group). PARTICIPANTS/MATERIALS SETTING METHODS: Women aged 20-35 years, undergoing ICSI with at least three follicles, were included. Quantum sensing of cGC and mGC free radicals, detected by either cytoplasm-located fluorescent nanodiamonds (FNDs) or mitochondria-targeted FNDs, was tracked for 2 h following FSH treatment in a magnetometry setup. Mitochondrial function analysis, as well as oxidative damage to DNA/RNA, lipids, and proteins, upon FSH exposure, was examined. MAIN RESULTS AND THE ROLE OF CHANCE: FSH-induced cytoplasmic and mitochondrial ROS increases in cGC and mGC (P < 0.01 in all concentrations after 2 h) while showing different patterns along time: cGC showed significantly larger cytoplasmic ROS change compared with mGC to physiological (P < 0.01) and supraphysiological (P < 0.05) concentrations of FSH. Significantly larger free radical changes were observed in the mitochondria compared to the cytoplasm in response to FSH (all concentrations in cGCs with P < 0.05; supraphysiological concentrations in mGCs with P < 0.05, P < 0.001, respectively) after 2 h. Mitochondrial basal respiration and ATP production were significantly increased upon FSH exposure to supraphysiological concentrations in both cGCs (P < 0.01) and mGCs (P < 0.05). However, no oxidative damage to GC DNA/RNA, proteins, or lipids was found upon FSH exposure at any concentration except elevated lipid peroxidation in the FSH group of 600 mIU/ml (P < 0.05). LARGE SCALE DATA: N/A. LIMITATIONS REASONS FOR CAUTION: The GCs came from females of different biological backgrounds and were stimulated before oocyte and GC retrieval, thereby increasing the risk of variation. In addition, the effects of long-term FSH exposure as well as the effects of the FSH-induced ROS on the oocyte remain to be investigated. WIDER IMPLICATIONS OF THE FINDINGS: We demonstrate that FSH of both physiological and supraphysiological concentrations induces free radical generation at subcellular levels, most notably in the mitochondria, while the elevated free radical load causes neglectable oxidative damage in both cGCs and mGCs. Our results suggest that the 'FSH Ootoxicity' hypothesis would not seem to be mediated by ROS in human GCs. STUDY FUNDING/COMPETING INTERESTS: This study is supported by the Abel Tasman Talent Program (ATTP) of the Graduate School of Medical Sciences of the University Medical Center Groningen/University of Groningen, The Netherlands, as well as an XS grant from NWO. Unrelated to the current work, A.H. is a member of an advisory board on the development and application of a lifestyle App for patients with infertility from Ferring Pharmaceutical Company, The Netherlands. R.S. is the founder of QT Sense B.V., who commercialize quantum sensing equipment. This article has no direct relation to the work of QT Sense B.V. The remaining authors have no conflicts of interest.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。